140 related articles for article (PubMed ID: 38547513)
1. N-Acetylcysteine: The Next Best Thing for Cardiovascular Interventions and Surgery?
Simeone B; Rocco E; Biondi-Zoccai G; Versaci F
J Cardiovasc Pharmacol; 2024 Jun; 83(6):534-536. PubMed ID: 38547513
[No Abstract] [Full Text] [Related]
2. N-Acetylcysteine for the prevention of renal dysfunction in high-risk patients undergoing coronary bypass graft surgery: an unfulfilled promise?
Filep JG
Crit Care Med; 2007 May; 35(5):1431-3. PubMed ID: 17446744
[No Abstract] [Full Text] [Related]
3. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y
Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531
[TBL] [Abstract][Full Text] [Related]
4. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients.
Haase M; Haase-Fielitz A; Bagshaw SM; Reade MC; Morgera S; Seevenayagam S; Matalanis G; Buxton B; Doolan L; Bellomo R
Crit Care Med; 2007 May; 35(5):1324-31. PubMed ID: 17414730
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine for the prevention of acute kidney injury after cardiac surgery.
Sisillo E; Marenzi G
J Clin Pharmacol; 2011 Nov; 51(11):1603-10. PubMed ID: 21233303
[No Abstract] [Full Text] [Related]
6. N-Acetylcysteine to Reduce Mortality for Patients Requiring Cardiac Catheterization or Cardiac Surgery: A Systematic Review and Meta-analysis.
Gakuba C; Dumitrascu AD; Marsan PE; Legallois D; Hanouz JL; Vivien D; Martinez de Lizarrondo S; Gauberti M; Cerasuolo D
J Cardiovasc Pharmacol; 2024 Jun; 83(6):580-587. PubMed ID: 38467037
[TBL] [Abstract][Full Text] [Related]
7. Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery?
Ashworth A; Webb ST
Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):303-8. PubMed ID: 20570977
[TBL] [Abstract][Full Text] [Related]
8. Renal insufficiency after cardiac surgery: a challenging clinical problem.
Kolh P
Eur Heart J; 2009 Aug; 30(15):1824-7. PubMed ID: 19589797
[No Abstract] [Full Text] [Related]
9. N-Acetylcysteine for Preventing of Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery: A Metaanalysis.
He G; Li Q; Li W; Wang L; Yang J; Zeng F
Heart Surg Forum; 2018 Dec; 21(6):E513-E521. PubMed ID: 30604677
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of N-Acetylcysteine in Preventing Acute Kidney Injury After Cardiac Surgery: A Meta-Analysis Study.
Mei M; Zhao HW; Pan QG; Pu YM; Tang MZ; Shen BB
J Invest Surg; 2018 Feb; 31(1):14-23. PubMed ID: 28060555
[TBL] [Abstract][Full Text] [Related]
11. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency.
Wijeysundera DN; Beattie WS; Rao V; Granton JT; Chan CT
Can J Anaesth; 2007 Nov; 54(11):872-81. PubMed ID: 17975231
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine to reduce renal failure after cardiac surgery: a systematic review and meta-analysis.
Naughton F; Wijeysundera D; Karkouti K; Tait G; Beattie WS
Can J Anaesth; 2008 Dec; 55(12):827-35. PubMed ID: 19050086
[TBL] [Abstract][Full Text] [Related]
13. N-acetylcysteine for the prevention of atrial fibrillation: beyond its antioxidant effect.
Barrios V; Escobar C; Calderon A; Lahera V
Eur Heart J; 2008 Nov; 29(22):2822-3; author reply 2823. PubMed ID: 18832774
[No Abstract] [Full Text] [Related]
14. The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial.
Tepel M; van der Giet M; Statz M; Jankowski J; Zidek W
Circulation; 2003 Feb; 107(7):992-5. PubMed ID: 12600912
[TBL] [Abstract][Full Text] [Related]
15. Effects of N-acetylcysteine on renal dysfunction in neonates undergoing the arterial switch operation.
Aiyagari R; Gelehrter S; Bove EL; Ohye RG; Devaney EJ; Hirsch JC; Gurney JG; Charpie JR
J Thorac Cardiovasc Surg; 2010 Apr; 139(4):956-61. PubMed ID: 19944431
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and non-surgical renal protective strategies for cardiac surgery patients undergoing cardiopulmonary bypass: a systematic review.
Tan SI; Brewster DJ; Horrigan D; Sarode V
ANZ J Surg; 2019 Apr; 89(4):296-302. PubMed ID: 30239089
[TBL] [Abstract][Full Text] [Related]
17. N-acetylcysteine in cardiac surgery: do the benefits outweigh the risks? A meta-analytic reappraisal.
Wang G; Bainbridge D; Martin J; Cheng D
J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):268-75. PubMed ID: 20638862
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery: a meta-analysis of published randomized controlled trials.
Liu XH; Xu CY; Fan GH
BMC Cardiovasc Disord; 2014 Apr; 14():52. PubMed ID: 24739515
[TBL] [Abstract][Full Text] [Related]
19. Role of N-acetylcysteine in prevention of contrast-induced nephropathy after cardiovascular procedures: a meta-analysis.
Misra D; Leibowitz K; Gowda RM; Shapiro M; Khan IA
Clin Cardiol; 2004 Nov; 27(11):607-10. PubMed ID: 15562929
[TBL] [Abstract][Full Text] [Related]
20. Impact of antioxidant supplementations on cardio-renal protection in cardiac surgery: an updated and comprehensive meta-analysis and systematic review.
Ali- Hasan- Al- Saegh S; Mirhosseini SJ; Tahernejad M; Mahdavi P; Shahidzadeh A; Karimi-Bondarabadi AA; Dehghan AM; Rahimizadeh E; Haddad F; Ghodratipour Z; Sarrafan-Chaharsoughi Z; Shahidzadeh A; Ghanei A; Lotfaliani M; Zeriouh M; Weymann A; Popov AF; Sabashnikov A
Cardiovasc Ther; 2016 Oct; 34(5):360-70. PubMed ID: 27344977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
